Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an update.
ResMed Inc has reported a change in beneficial ownership as Peter C. Farrell, the Chairman emeritus, disposed of 2,000 shares of ResMed common stock on April 2, 2025, under a pre-established Rule 10b5-1 plan. This transaction reflects ongoing management of personal holdings by company executives, which may influence investor perceptions and the company’s stock market performance.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of equipment related to sleep disorders, respiratory care, and other medical devices. The company is known for its innovative solutions aimed at improving the quality of life for patients with chronic diseases.
YTD Price Performance: -7.71%
Average Trading Volume: 1,185,998
Technical Sentiment Signal: Sell
Current Market Cap: A$49.86B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.